sounds reasonable...my main concern is this though:
why is a company like INFI priced at $41/share while we sit sub $2...granted I have only looked really quickly, but our pipeline seems to be more advanced...I also didn't look at share structure etc. It just appears to me that there are many companies like the one I just mentioned that have far higher pps while offering much less...this concerns me...why, IF we do have a potential oncology SOC (I am not using the term blockbuster)...why why why do we sit at<$2